Guideline-based Medical Quality Management in Dialysis Motivation and structuring of a quality-management system and integration of earlier disease stages of chronic renal failure;Leitlinien-gestütztes medizinisches Qualitätsmanagement in der Dialyse Motivation und Aufbau eines Qualitätsmanagement-Systems sowie Integration früherer Erkrankungsstadien der chronischen Niereninsuffizienz

Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung

Volumn 98, Issue 7, 2004, Pages 609-616

  Stoffel, Markus P ^a   Lauterbach, Karl W ^a   Baldamus, Conrad A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chronic kidney; Dialysis; Quality indicators; Quality management

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; DIALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; KIDNEY FAILURE; MEDICAL ASSESSMENT; MEDICAL SERVICE; MEDICAL STAFF; PROCESS DESIGN;

HUMANS; KIDNEY FAILURE, CHRONIC; PRACTICE GUIDELINES; QUALITY ASSURANCE, HEALTH CARE; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

EID: 7044286277     PISSN: 14317621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brenner BNM, Cooper ME, de Zeeuw D, et al (2002) Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. N Engl J Med 345:861-9.
2. Brunner FP, Selwood NH (1990) Results of renal replacement therapy in Europe, 1980 to 1987. Registration Committee of the EDTA-ERA. Am J Kidney Dis 15:384-396.
3. Charra B, Calemard E, Ruffet M, et al (1992) Survival as an index of adequacy of dialysis. Kidney Int 41:1286-91.
4. Depner TA, Daugirdas JT (1996) Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 7:780-5.
5. Donabedian A (1986) Criteria and standards for quality assessment and monitoring. Qual Rev Bull. 12:99-108.
6. ESRD Core Indicators Project: 1996 Annual Report. Department of Health and Human Services, Health Care Financing Administration, Health Standards and Quality Bureau, January 1997 (http://www.hcfa.gov/quality)
7. Hays RD, Kalich JD, Mapes DL, et al (1994) Development of the kidney quality of life (KDQOL) instrument. Qual Life Res 3:329-38.
8. Innes A, Charra B, Burden RP, et al (1999) The effect of long, slow haemodialysis on patient survival. Nephrol Dial Transplant 14:919-22.
9. Köck CM (2001) Qualitätsmanagement: Definition und Abgrenzung. In: Lauterbach KW, Schrappe M (eds.) Gesundheitsökonomie, Qualitätsmanagement und Evidence-based medicine. Stuttgart: Schattauer.
10. Jacobs C, Hörl WH, Macdougall I, et al (2000) European best practice guidelines 9-13: anaemia management. Nephrol Dial Transplant 15 suppl 4:33-42.
11. Lenz MJ, Hochreutener MA (2001) The LORAS Project and quality assurance. In four years from input- to outcome-oriented financing in public health. 1: The LORAS Project. Z Arztl Fortbild Qualitatssich 95:137-9.
12. Mosser G (1996) Clinical process improvement: engage first, measure later. Qual Manag Health Care. 4:11-20.
13. Nebel M (2002) Behandlungskosten der Nierenersatztherapie in Deutschland 1999. Nieren- und Hochdruckkrankheiten 31:85-92.
14. Nierenersatztherapie in Deutschland. Berichte über Dialysebehandlung und Nierentransplantation 1995-2000. Qualitätssicherung Niere (QuaSi-Niere gGmbH), Berlin. 2001. http://www.quasi-niere.de/world_d.htm
15. NKF-DOQI (1997) Clinical practice guidelines. Am J Kidney Dis 30 suppl. 3:S1-S240. http://www.doqi.org
16. Parmar MS (2002) Chronic renal disease. Br Med J 325:85-90.
17. Perkins BA, Ficociello LH, Silva KH, et al (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285-93.
18. Rayner HC, Pisoni RL, Bommer J, et al (2004) Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 19:108-20.
19. Ruggenenti P, Perna A, Ghepardi G, et al (1999) Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria Lancet 354:359-64.
20. Sackett DL, Rosenberg WMC, Gray JA, et al (1996) Evidence-based medicine: what it is and what it isn't. Br Med J 312:71-2.
21. Scribner BH, Oreopoulos, DG (2002) The Hemodialysis Product (HDP): A better index of dialysis adequacy than Kt/V. Dialysis Transplantation 31:13-5.
22. US Renal Data System: USRDS 2001 Annual Data Report. The National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2001. http://www.usrds.org
23. Wolfe RA, Hulbert-Shearon TE, Roys EC, Port FK (2000) Standardized mortality and hospitalization ratios by dialysis unit practice pattern of anemia adjusted for dialysis dose and vascular access type. J Am Soc Nephrol 11:247A.
24. Wolfe RA (1994) The standardized mortality ratio revisited: improvements, innovations, and limitations. Am J Kidney Dis 24:290-7.